Participants 48 125 3
after oral microcrystalline and sustained-release preparations in asthmatics.
Participants 198 370 7
serum in 13 asthmatic patients after single and multiple oral dosage of a microcrystalline theophylline tablet (Nuelin) and a sustained-release preparation (Nuelin Retard).
